Nearly 72.2 percent of the eyes improved and 27.8 percent emained stable
Macular thickness also decreased in most eyes. Patients who received two or more injections were significantly more likely to improve.
"Large, randomized controlled clinical trials are needed to confirm IVB's efficacy and safety in treating these conditions," said Arevalo.
"The results for DMME are very promising and suggest that combining anti-VEGF treatment with laser therapy may prove useful.
"Also, once further study is completed, unresolved CME post-cataract surgery should be considered for inclusion as an indication for use of IVB," he added.
The study appears in the journal of the American Academy of phthalmology.
Source-ANI
TAN